RAD51 Inhibitor Reverses Etoposide-Induced Genomic Toxicity and Instability in Esophageal Adenocarcinoma Cells.

Liao, Chengcheng; Zhao, Jiangning; Kumar, Subodh; Chakraborty, Chandraditya; Talluri, Srikanth; Munshi, Nikhil C; Shammas, Masood A

Liao, Chengcheng; Zhao, Jiangning; Kumar, Subodh; Chakraborty, Chandraditya; Talluri, Srikanth; Munshi, Nikhil C; Shammas, Masood A.

Afiliación

Liao C; Dana Farber Cancer Institute, USA.
Zhao J; Veterans Administration Boston Healthcare System, USA.
Kumar S; Dana Farber Cancer Institute, USA.
Chakraborty C; Dana Farber Cancer Institute, USA.
Talluri S; Veterans Administration Boston Healthcare System, USA.
Munshi NC; Dana Farber Cancer Institute, USA.
Shammas MA; Dana Farber Cancer Institute, USA.

Arch Clin Toxicol (Middlet) ; 2(1): 3-9, 2020.

Article en En | MEDLINE | ID: mdl-32968740

Palabras clave

Chemotherapy; Esophageal adenocarcinoma; Etoposide; Genomic evolution; Genomic instability; Homologous recombination; RAD51

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Idioma: En Revista: Arch Clin Toxicol (Middlet) Año: 2020 Tipo del documento: Article País de afiliación: Estados Unidos

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google